Point taken.
Regarding pricing, 7730 has been around long enough that I suspect the R&D costs and the cost of clinical trials have long been recovered. A stoma is essentially an open wound. The purity of the material is of high importance. Some years ago I was the technical liaison between a group of our R&D folks and the construction personnel for the construction of a Class 100 (can’t remember what the current industry designation is) clean room. Anytime you need a space controlled for temperature, humidity (probably small tolerances for both) and particulate contamination, it becomes expensive to operate and it has to run 24/7 – 365. There also likely complicated maintenance, cleaning and certification procedures that are mandated for the Food & Drug Administration. Volume comes into play also. Given what the product is intended to do, I certainly hope that the market size is fairly limited, but I don’t know what it is. At any rate, it certainly isn’t like the market for aspirin or ibuprofen…